7. History
2012
Expands R&D into virology,
immunology, and oncology,
establishing key pharma
objectives
2014
Acquires ImmuVen, Infinity
Pharmaceuticals, fails to
acquire Shire
2011
Abbott Laboratories announced
pharma spin off AbbVie
2013
Officially splits AbbVie into
independent company, IPO
2015
Acquires Pharmacyclics,
gaining sales of ibrutinib
2016
Acquires Stemcentrx to expand
oncology research
2017
AbbVie reports record year,
shares gaining over 50% in price
2018
Humira (highest gross revenue
drug) patent expires in
countries around the world